David L. Cooper
162 works · 3,719 citations · h-index 34
Top works
- The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin.
- Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
- Retention of CD44 introns in bladder cancer: Understanding the alternative splicing of pre‐mRNA opens new insights into the pathogenesis of human cancers
- Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
- The complex CD44 transcriptional unit: Alternative splicing of three internal exons generates the epithelial form of CD44
- Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study
- Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study
- Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
- To metastasize or not? Selection of CD44 splice sites
- Adhesive Interactions between Alternatively Spliced CD44 Isoforms
- Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics
- Bovine corneal protein 54K (BCP54) is a homologue of the tumor-associated (class 3) rat aldehyde dehydrogenase (RATALD)
- Degradation rates of acetylcholine receptors can be modified in the postjunctional plasma membrane of the vertebrate neuromuscular junction.
- Alternative Splicing of CD44 pre-mRNA in Human Colorectal Tumors
- CD44V6 expression in human colorectal carcinoma
- Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
- Assessment of acquired hemophilia patient demographics in the United States
- Haemophilia Experiences, Results and Opportunities ( HERO ) Study: Influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia
- Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18–30 years) with hemophilia
- Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia